Жирные кислоты омега-3/рыбий жир

Appel, L. J., Е. R. Miller III, A. J. Seidler, et al. 1993. Does supplementation of diet with «fish oil» reduce blood pressure? A meta-analysis of controlled clinical trials. Archives of Internal Medicine 153(12): 1429–1438.

Hiroshima, F., A. M. Parow, A. L. Stoll, et al. 2004. Omega-3 fatty acid treatment and T(2) whole brain relaxation times in bipolar disorder. American Journal of Psychiatry 161(10): 1922–1924.

Stoll, A. L., К. E. Damico, B. P. Daly, et al. 2001. Methodological considerations in clinical studies of omega-3 fatty acids in major depression and bipolar disorder. World Review of Nutrition and Dietetics 88: 58–67.

Глава 6

СДВ

Amen, D. G. 2001. Healing ADD: The Breakthrough Program That Allows You to See and Heal the 6 Types of ADD. New York: Putnam.

Benton, D., and G. Roberts. 1988. Effect of vitamin and mineral supplementation on intelligence of a sample of schoolchildren. Lancet 1(8578): 140–143.

McCann, D., A. Barrett, A. Cooper, et al. 2007. Food additives and hyperactive behaviour in 3-year-old and 8/9-year-old children in the community: A randomised, double- blinded, placebo- controlled trial. Lancet 370(9598): 1560–1567.

Pelsser, L. M., K. Frankena, J. Toorman, et al. A randomised controlled trial into the effects of food on ADHD. European Child & Adolescent Psychiatry.

Жирные кислоты омега-3/рыбий жир

Colter, A. L, С. Cutler, and К. A. Meckling. 2008. Fatty acid status and behavioural symptoms of attention deficit hyperactivity disorder in adolescents: a casecontrol study. Nutrition Journal 7: 8.

Johnson, M., S. Ostlund, G. Fransson, et al. Omega-3/Omega-6 fatty acids for attention deficit hyperactivity disorder: A randomized placebo-controlled trial in children and adolescents. Journal of Attention Disorders.

Richardson, A. J., and P. Montgomery. 2005. The Oxford- Durham study: A randomized, controlled trial of dietary supplementation with fatty acids in children with developmental coordination disorder. Pediatrics 115(5): 1360–1366.

Ацетил-L-карнитин

Arnold, L. E., A. Amato, H. Bozzolo, et al. Acetyl-L-carnitine (ALC) in attentiondeficit / hyperactivity disorder: A multi- site, placebo-controlled pilot trial. Journal of Child and Adolescent Psychopharmacology 17(6): 791–802.

Bianchetti, A., R. Rozzini, and M. Trabucchi. 1992. Effects of acetyl- L-carnitine in Alzheimer’s disease patients unresponsive to acetylcholinesterase inhibitors. Current Medical Research and Opinion 19(4): 350–353.

Bowman, B. 1992. Acetyl- carnitine and Alzheimer’s disease. Nutrition Reviews 50: 142–144.

Rossini, М., О. Di Munno, G. Valentini, et al. 2007. Double-blind, multicenter trial comparing acetyl- L- carnitine with placebo in the treatment of fibromyalgia patients. Clinical and Experimental Rheumatology 25(2): 182–188.

Tempesta, E., L. Casella, C. Pirrongelli, et al. L-acetylcarnitine in depressed elderly subjects. A cross-over study vs. placebo. Drugs Under Experimental 8c Clinical Research 13(7): 417–423.

DL-фенилаланин

Baker, G. B., R. A. Bornstein, A. C. Rouget, et al. 1991. Phenylethylamin-ergic mechanisms in attention- deficit disorder. Biological Psychiatry 29(1): 15–22.

Beckmann, H., M. A. Strauss, and E. Ludolph. 1977. DL- phenylalanine in depressed patients: An open study. Journal of Neural Transmission 41(2–3): 123–134.

Walsh, N. E., S. Ramamurthy, L. Schoenfeld, et al. 1986. Analgesic effectiveness of

ГАМК

Abdou, A. M., S. Higashiguchi, K. Horie, et al. 2006. Relaxation and immunity enhancement effects of gamma- aminobutyric acid (GABA) administration in humans. Biofactors 26(3): 201–208.

Chovanova, Z., J. Muchova, M. Sivonova, et al. Effect of polyphenolic extract, Pycnogenol, on the level of 8- oxoguanine in children suffering from attention deficit/hyperactivity disorder. Free Radical Research 40(9): 1003–1010.

Dvorakova, M., M. Sivonova, J. Trebaticka, et al. 2006. The effect of polyphenolic extract from pine bark, Pycnogenol on the level of glutathione in children suffering from attention deficit hyperactivity disorder (ADHD). Redox Report 11(4): 163–172.

L-тирозин

Chiaroni, P., J. М. Azorin, Р. Bovier, et al. 1990. A multivariate analysis of red blood cell membrane transports and plasma levels ot L- tyrosine and L- tryptophan in depressed patients before treatment and after clinical improvement. Neuropsychobiology 23(1): 1–7.

Kelly, G. S. 1999. Nutritional and botanical interventions to assist with the adaptation to stress. Alternative Medicine Review 4(4): 249–265.

Meyers, S. 2000. Use of neurotransmitter precursors for treatment of depression. Alternative Medicine Review 5(1): 64–71.

Wagenmakers, A. J. 1999. Amino acid supplements to improve athletic performance. Current Opinion in Clinical Nutrition and Metabolic Care 2(6): 539–544.

S-аденозилметионин (SAMe)

Baldessarini, R. J. 1987. Neuropharmacology of S- adenosyl- L- methionine. American Journal of Medicine 83(5A): 95-103.

Bell, К. M., et al. 1994. S- adenosylmethionine blood levels in major depression: changes with drug treatment. Acta Neurologica Scandi-navica Supplement 154: 15–18.

F ava, M., A. Giannelli, V. Rapisarda, et al. 1995. Rapidity of onset of the antidepressant effect of parenteral S- adenosyl- L- methionine. Psychiatry Research 56(3): 295–297.

Gaby, A. R. 1999. Natural treatments for osteoarthritis. Alternative Medicine Review 4(5): 330–341.

Konig, B. 1987. A long-term (two years) clinical trial with S- adenosylmethionine for the treatment of osteoarthritis. American Journal of Medicine 83(5A): 89–94.

Leventhal, L. J. 1999. Management of fibromyalgia. Annals of Internal Medicine 131: 850–858.

Зверобой

Behnke, К., G. S. Jensen, Н. J. Graubaum, et al. 2002. Hypericum perforatum versus fluoxetine in the treatment of mild to moderate depression. Advances in Therapy 19(1): 43–52.

Brenner, R., V. Azbel, S. Madhusoodanan, et al. 2000. Comparison of an extract of hypericum (LI 160) and sertraline in the treatment of depression: A doubleblind, randomized pilot study. Clinical Therapeutics 22(4): 411–419.

Kalb, R., R. D. Trautmann- Sponsel, and M. Kieser. 2001. Efficacy and tolerability of hypericum extract WS 5572 versus placebo in mildly to moderately depressed patients. A randomized double- blind multicenter clinical trial. Pharmacopsychiatry 34(3): 96-103.

Simeon, J., M. Nixon, R. Milin, et al. 2005. Open- label pilot study of St. Johns wort in adolescent depression. Journal of Child & Adolescent Psychopharmacology 15(2): 293–301.

Теанин

Bryan, J. 2008. Psychological effects of dietary components of tea: caffeine and Ltheanine. Nutrition Review 66(2): 82–90.

Dimpfel, W., A. Kler, E. Kriesl, et al. 2007. Source density analysis of the human EEG after ingestion of a drink containing decaffeinated extract of green tea enriched with L- theanine and theogallin. Nutritional Neuroscience 10(3–4): 169–180.

Nobre, A. C., A. Rao, and G. N. Owen. 2008. L- theanine, a natural constituent in tea, and its effect on mental state. Asia Pacific Journal of Clinical Nutrition 17(Suppl. 1): 167–168.

Rogers, P. J., J. E. Smith, S. V: Heatherley, et al. 2008. Time for tea: Mood, blood pressure and cognitive performance effects of caffeine and theanine administered alone and together. Psychopharmacology 195(4): 569–577.

Цинк

Arnold, L. Е., Н. Bozzolo, J. Hollway, et al. 2005. Serum zinc correlates with parent- and teacher- rated inattention in children with attention- deficit/hyperactivity disorder. Journal of Child & Adolescent Psychopharmacology 15(4): 628–636.

Bilici, M., F. Yildirim, S. Kandil, et al. 2004. Double- blind, placebo-controlled study of zinc sulfate in the treatment of attention deficit hyperactivity disorder. Progress in Neuropsychopharmacology & Biological Psychiatry 28(1): 181–190.

Yorbik, O., M. F. Ozdag, A. Olgun, et al. 2008. Potential effects of zinc on information processing in boys with attention deficit hyperactivity disorder. Progress in Neuropsychopharmacology & Biological Psychiatry 32(3): 662–667.

Глава 7

Amen, D. G., and L. C. Routh. 2003. Healing Anxiety and Depression. New York: Putnam.

Поиск по сайту: